FTC Patent Strategy Aims to Lower Drug Prices
In a move intended to tackle the soaring costs of prescription drugs, the Federal Trade Commission (FTC) has embarked on an initiative targeting patents associated with 20 brand-name medications. Among them is the widely used weight-loss injection Ozempic. This maneuver by federal regulators is characterized as an effort to dismantle certain practices within the pharmaceutical…